- Home
- HRTX vs HSDT Comparison
HRTX vs HSDT Comparison
Compare HRTX & HSDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.45
HOLD
Current Price
$1.64
Company Overview
Basic Information| Metric | HRTX | HSDT |
|---|---|---|
| Founded | 1983 | N/A |
| Country | United States | United States |
| Employees | N/A | 21 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 90.1M | 95.2M |
| IPO Year | 2007 | N/A |
Fundamental Metrics
Financial Performance| Metric | HRTX | HSDT |
|---|---|---|
| Price | $0.45 | $1.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $4.50 | $4.00 |
| AVG Volume (30 Days) | ★ 2.9M | 214.6K |
| Earning Date | 05-11-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $154,904,000.00 | N/A |
| Revenue This Year | $15.28 | $91.56 |
| Revenue Next Year | $20.29 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7.36 | N/A |
| 52 Week Low | $0.38 | $1.19 |
| 52 Week High | $1.93 | $25.50 |
Technical Indicators
Market Signals| Indicator | HRTX | HSDT |
|---|---|---|
| Relative Strength Index (RSI) | 43.90 | 45.18 |
| Support Level | $0.39 | $1.59 |
| Resistance Level | $0.46 | $1.85 |
| Average True Range (ATR) | 0.03 | 0.09 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 52.81 | 3.85 |
Price Performance
Historical Comparison HRTX
HSDT
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
About HSDT Helius Medical Technologies Inc. (DE)
Solana Co is a publicly listed digital asset treasury established in partnership with Pantera and Summer Capital. The company is dedicated to acquiring Solana (SOL) and aims to maximize SOL per share by strategically leveraging capital market opportunities and on-chain activities.